BIMI International Medical Inc. / Fundamentals
Income statement
- Net revenue
€5.04M - Cost of goods sold
€2.99M - Gross profit
-€2.64M - SG&A expenses
€7.74M - R&D expenses
€0.00 - EBITDA
-€9.02M - D&A
€145.69K - EBIT
-€7.48M - Interest expenses
€2.77M - EBT
-€11.95M - Tax expenses
€103.12K - Net income
-€12.71M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€10.29M - Changes in working capital
-€1.20M - Operating cash flow
-€1.86M - Capex
€520.28K - Other investing cash flow
€1.09M - Net investing cash flow
-€827.74K - Total cash dividends paid
€0.00 - Issuance of common stock
€5.69M - Debt repayment
€246.98K - Other financing cash flow
€1.19M - Net financing cash flow
€2.82M - Foreign exchange effects
-€11.58K - Net change in cash
-€45.44K - Cash at end of period
€856.49K - Free cash flow
-€1.34M
Balance sheet
- Cash and cash equivalents
€856.49K - Cash and short-term investments
€856.49K - Total receivables
€4.65M - Inventory
€6.11M - Other current assets
€9.38M - Total current assets
€20.99M - Property, plant & equipment
€3.95M - Goodwill
€1.78M - Intangible assets
€403.35K - Long-term investments
€0.00 - Other non-current assets
€2.91M - Total non-current assets
€9.20M - Total assets
€30.19M - Accounts payable
€8.99M - Short-term debt
€1.72M - Other current liabilities
€5.97M - Total current liabilities
€17.37M - Long-term debt
€2.13M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€1.96M - Total non-current liabilities
€4.08M - Total liabilities
€21.45M - Common stock
€5.75K - Retained earnings
-€61.54M - Other equity
-€975.45K - Total equity
€8.74M - Total liabilities and shareholders' equity
€30.19M
Company information
- Market capitalization
€1.19K - Employees
296 - Enterprise Value
€3.13M
Company ratios
- Gross margin
-
-52.3% Much worse than peer group: 38.9% - EBITDA margin
-
-179.0% Much better than peer group: -3,183.1% - EBIT margin
-
-148.5% Much better than peer group: -2,652.8% - EBT margin
-
-237.2% Much better than peer group: -11,710.3% - Net margin
-
-252.4% Much better than peer group: -11,711.9% - ROE
-
-145.5% Much worse than peer group: 107.3% - ROA
-
-42.1% Much better than peer group: -36,067.1% - Asset turnover
-
16.7% Much worse than peer group: 220.4% - FCF margin
-
-47.3% Much better than peer group: -4,557.4% - FCF yield
-200,088.3% - Efficiency ratio
279.0% - Net sales per employee
-
€17.02K - Net income per employee
-
-€42.95K